Add time:07/14/2019         Source:sciencedirect.com

Existing antifolate antimalarial drugs have shown resistance due to the mutations at some amino acid positions of Plasmodium falciparum DHFR-TS. In the present study, to overcome this resistance, a new series of hybrid 4-aminoquinoline-triazine derivatives were designed and docked into the active site of Pf-DHFR-TS (PDB i.d. 1J3K) using validated CDOCKER protocol. Binding energy was calculated by applying CHARMm forcefield. Binding energy and the pattern of interaction of the docked compounds were analysed. Fifteen compounds were selected for synthesis based on their binding energy values and docking poses. Synthesized compounds were characterised by FTIR, 1H NMR, 13C NMR, mass spectroscopy and were screened for antimalarial activity against 3D7 strain of Plasmodium falciparum.

We also recommend Trading Suppliers and Manufacturers of N~2~,N~2~-diethyl-N~4~,N~4~,N~6~,N~6~-tetramethyl-1,3,5-triazine-2,4,6-triamine (cas 16268-75-0). Pls Click Website Link as below: cas 16268-75-0 suppliers